Wilmer Cutler Pickering Hale and Dorr represented Akamai Technologies, Inc., and Davis Polk & Wardwell advised the representatives of the initial purchasers in the offering. Akamai...
Akamai Technologies’ $1.1 Billion Convertible Senior Notes Offering
Eli Lilly’s $487 Million Acquisition of Akouos
Kirkland & Ellis represented Lilly, while Wilmer Cutler Pickering Hale and Dorr represented Akouos in the transaction. Eli Lilly and Company (NYSE: LLY) announced its acquisition...
Amylyx Pharmaceuticals’ $190 Million IPO
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal while Goodwin Procter represented Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company...
PerkinElmer’s $5.25 Billion Acquisition of BioLegend
Wilmer Cutler Pickering Hale and Dorr advised PerkinElmer on the deal while Pillsbury Winthrop Shaw Pittman represented BioLegend. PerkinElmer, a global leader committed to innovating for...